Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Latest Breaking News

Showing Original Post only (View all)
 

brooklynite

(96,882 posts)
Tue Sep 22, 2020, 10:04 AM Sep 2020

Axios-Ipsos poll: Vaccine resistance grows [View all]

Source: Axios

The share of Americans eager to try a first-generation coronavirus vaccine dropped significantly in the latest installment of the Axios-Ipsos Coronavirus Index, as President Trump hyped suggestions that one could be ready before the election.

Why it matters: As the U.S. reaches a milestone of 200,000 deaths, this underscores the risks of politicizing the virus and its treatments.
* The trend is taking place among Republicans as well as Democrats.
* It's another warning of the potential difficulties health authorities will face in convincing enough Americans that a vaccine is safe and effective.

The big picture: Americans don't see the vaccine as a silver bullet right now. Many respondents in Week 25 of our national survey feel it's risky and at least want to wait to see how others do. And only half are prepared to pay out of pocket for it.
* Just 13% say they'd be willing to try it immediately.
* This all comes against the backdrop of an uncertain return-to-school experiment. One in three parents of schoolchildren says there already have been virus-related scares or outbreaks in their school district.

Read more: https://www.axios.com/axios-ipsos-poll-coronavirus-index-vaccine-doubts-e9205f29-8c18-4980-b920-a25b81eebd84.html

15 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Latest Discussions»Latest Breaking News»Axios-Ipsos poll: Vaccine...